A detailed history of Aquatic Capital Management LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Aquatic Capital Management LLC holds 12,558 shares of CORT stock, worth $948,631. This represents 0.02% of its overall portfolio holdings.

Number of Shares
12,558
Previous 55,458 77.36%
Holding current value
$948,631
Previous $4.07 Million 74.37%
% of portfolio
0.02%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$67.17 - $83.9 $2.88 Million - $3.6 Million
-42,900 Reduced 77.36%
12,558 $1.04 Million
Q2 2025

Aug 14, 2025

BUY
$62.24 - $91.93 $712,025 - $1.05 Million
11,440 Added 25.99%
55,458 $4.07 Million
Q1 2025

May 15, 2025

BUY
$49.85 - $114.22 $472,777 - $1.08 Million
9,484 Added 27.46%
44,018 $5.03 Million
Q4 2024

Feb 14, 2025

BUY
$44.66 - $60.85 $787,534 - $1.07 Million
17,634 Added 104.34%
34,534 $1.74 Million
Q3 2024

Nov 14, 2024

BUY
$29.51 - $46.26 $463,307 - $726,282
15,700 Added 1308.33%
16,900 $781,000
Q2 2024

Aug 14, 2024

SELL
$22.21 - $34.48 $133,260 - $206,879
-6,000 Reduced 83.33%
1,200 $38,000
Q1 2024

May 15, 2024

BUY
$21.1 - $27.46 $118,160 - $153,776
5,600 Added 350.0%
7,200 $181,000
Q4 2023

Feb 14, 2024

BUY
$24.82 - $32.88 $39,712 - $52,608
1,600 New
1,600 $52,000
Q2 2023

Aug 14, 2023

BUY
$21.44 - $25.15 $188,672 - $221,320
8,800 New
8,800 $196,000
Q4 2022

Feb 14, 2023

BUY
$19.95 - $29.96 $718,200 - $1.08 Million
36,000 New
36,000 $731,000
Q2 2022

Aug 15, 2022

SELL
$17.33 - $25.3 $6,931 - $10,120
-400 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$16.53 - $25.21 $6,612 - $10,084
400 New
400 $9,000

Others Institutions Holding CORT

About CORCEPT THERAPEUTICS INC


  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.09B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Aquatic Capital Management LLC Portfolio

Follow Aquatic Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aquatic Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aquatic Capital Management LLC with notifications on news.